KNOWLEDGE BANK

Interviews

Advancing Pharma Innovation & Drug Development | Thermo Fisher Scientific | ISPE 2026 | Pharma Focus Asia

Senior Director, Head of Business Development APAC, Thermo Fisher Scientific
Koji Tanimoto is Senior Director of Biotech Account Management APAC at Thermo Fisher Scientifics Pharma Services Group Previously he served as Senior Director and Head of Business Development for Asia Pacific and Japan at Patheon also holding the title of Director at Patheon In Japan Since he led business development across both Patheons CDMO operations and Fisher Clinical Services clinical trial...

Articles

Impact Assessment of US Tariff Threat on Indian Healthcare Export

The ongoing tariff fusillades and retorts by the economies like China have precipitated several conundrums and made the trade future nebulous The flat per cent of reciprocal tariff across the sectors include the medical device also The pharmaceutical sector has been kept exempted The current tariff of the Indian drug to the US is zero while the tariffs on US medicines by India is per cent per c...

Research Insights

Temperature Excursion Management – A Novel Approach Of Quality System In Pharmaceutical Industry

Abstract Quality of pharmaceutical product largely depends upon by the environment controls during its storage and handling Each pharmaceutical product should be handled and stored under specified storage condition labelled on product information data sheet or product pack Hence the temperature excursions during receipt of raw materials manufacturing of phar

Case Studies

Analytics Stories: A Case Study from Quintiles

As I have shared within other posts within this series businesses are using analytics to improve their internal and external facing business processes and to strengthen their right to win within the markets that they operate For pharmaceutical businesses strengthening the right to win begins and ends with the drug product development lifecycle I remember for example t...

Techno Trends

Biogen Develops QALSODY®, the First Therapy to Treat a Rare, Genetic Form of ALS

Biogen has developed QALSODY a groundbreaking therapy for adults with amyotrophic lateral sclerosis linked to a mutation in the superoxide dismutase gene

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Endocrine Disrupting Compounds (EDCs)

Sintu Kumar Samanta

Sintu Kumar Samanta has been working as an Assistant professor in IIIT Allahabad, India. He did Ph.D. and post-doctoral research from IIT Kharagpur and IISc Bangalore, India respectively. He is working in the area of Biochemistry and Nanobiotechnology. He published research work in several international journals and filed one Indian patent.

 

 
Pavan Kumar Gautam

Pavan Kumar Gautamis presently working as a Post-Doctoral Fellow in the Department of Applied Sciences at IIIT Allahabad, India. He obtained Ph.D. from the University of Allahabad, India. His area of research is synthesis of nanoparticles for water remediation. He published his research work in many international journals.

 

2

Nanotechnology based Drug Delivery for Infectious Diseases

Dr. Vinod Kumar Rajana

Dr. Vinod Kumar Rajana, Assistant Professor of Pharmaceutics, specializes in nanotechnology, bioassays, and infectious disease research. With expertise in nanoparticle synthesis, biotechnology, and drug delivery, his work integrates green chemistry with pharmaceutical innovation to develop sustainable, low-cost nanomaterials for topical antifungal and anticancer therapies, water purification, and biomedical applications.

3

Why tier-2 and tier-3 cities are not included for clinical research

Krutikesh Age

Co-Founder at DPHS Pvt. Ltd., Dr. Krutikesh Age is a researcher and a visionary committed towards propelling the field of clinical research and healthcare expansion in India. As the Co-founder of DPHS, Krutikesh manages varied key roles including Leadership, developing business and marketing strategies and Networking to name a few. It is through the deep understanding of clinical research and market dynamics that he has been instrumental in expanding the operations of DPHS in the past few years.

 

4

Trump Tariff Tyranny and Pharma Preparedness

Dr. M Aamir Mirza

Dr. M. Aamir Mirza is working as an Assistant Professor in the Department of Pharmaceutics, Jamia Hamdard, an NIRF Rank 1 institute and a NAAC ‘A+” grade deemed to be University. He has a multifaceted career portfolio adorned with both industry and academic accomplishments. During his industry stay he became a seasoned scientist and dealt with challenging NCE/NDA development. He is on advisory boards of some international research-based companies of India, New Zealand and Europe. Academics and Research being close to his heart, he has published more than 110 manuscripts in the journals of international repute and has been granted 02 Indian patent and filed for 04. He has contributed several chapters in books published by reputed authors like Elsevier and Bentham. He is amongst the very few scientists globally who has an expertise in Humic substances research. A well-travelled scientist; he has delivered scientific addresses in countries like USA, Austria, Japan, Netherlands, Turkey, Estonia, Spain and Russia. He has been Elite Fellow at University of Malaya (Malaysia) for the last 5 years where he takes classes on the topics related to industrial pharmacy.

5

The Emergence of Organ-on-chips for Diseases Studies and Drug Development

Giuseppe Maruccio

Giuseppe Maruccio is Full Professor at Department of Mathematics and Physics – University of Salento and head of Omnics Research Group which comprises researchers with different backgrounds from physics to life sciences working in cross-disciplinary areas  with applications from -onics (electronics, spintronics and magnonics) to -omics technologies (genomics, proteomics and cellomics)

 

Anna Grazia Monteduro

Anna Grazia Monteduro is researcher at Department of Mathematics and Physics - University of Salento in Lecce (Italy) and carries out her research activity within Omnics Research Group in the fields of (i) sensors, lab on chip and organ on chip; (ii) Nanoelectronics, spintronics, nanomagnetism and applied superconductivity.

 

Silvia Rizzato

Silvia Rizzato is researcher at the Department of Mathematics and Physics - University of Salento and carries out her research activity within Omnics Research Group on the development of new devices and processes for sensing and spintronics, including surface acoustic waves devices, electrochemical sensors and colloidal lithography for LSPR sensors.

 

Giusi Caragnano

Giusi Caragnano is a PhD student in Nanotechnologies at the University of Salento - CNR Nanotec and she is part of the Omnics Research Group. Her research activity concerns development of the Organ-on-chip to support the treatment of both chronic and cancerous gastrointestinal diseases

 

press releasesRead more...

Ecolab Opens Advanced Resin Manufacturing Facility in China

Demand for advanced purification solutions is growing as industries look to improve performance while using less water and fewer natural resources Industries are increasingly turning to advanced separation purification

Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer

Waters Corporation NYSE WAT today announced the global commercial launch of the BD FACSDiscover A Cell Analyzer which uniquely combines exceptional spectral resolution and sensitivity with industryleading standardization

Ginkgo Bioworks to Build an Autonomous Lab at Novo’s New U.S. R&D Site in Waltham

Ginkgo Bioworks NYSE DNA today announced that it has been selected to build an autonomous lab powered by its Reconfigurable Automation Cart RAC architecture at Novos new RD site in Waltham Massachusetts

Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA

Altruist Biologics a worldclass contract development and manufacturing organization CDMO and wholly owned subsidiary of Innovent Biologics HK congratulates its strategic partner LongBio Pharma

Sanofi and Cheplapharm to create new strategic partnership in mature medicines

Sanofi and Cheplapharm a European leader in wellestablished medicines today announced their intention to create a strategic partnership under which Cheplapharm would take over from Sanofi a selection

Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions

Eli Lilly and Company NYSE LLY today announced the successful completion of its acquisition of AtaiBeckley Inc AtaiBeckley is a clinicalstage biopharmaceutical company developing rapidacting

EventsRead more...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

22 - 23

Sep 2026

22 - 24

Sep 2026

28 - 01

Sep 2026

29 - 01

Sep 2026

10th IPF Summit 2026

Boston, MA, USA

LATEST NEWSRead more...

QurCan Therapeutics Enters into Collaboration with Lilly Advance Nucleic Acid Therapies for Nervous System Diseases

QurCan Therapeutics has entered into an exclusive research and collaboration agreement with Eli Lilly and Company to develop nucleic acid therapies for diseases affecting the central nervous system CNS and peripheral nervous system PNS

BostonGene Expands Collaboration with Dana-Farber Cancer Institute for Breast Cancer Research

BostonGene has expanded its scientific collaboration with DanaFarber Cancer Institute to study the biological mechanisms involved in breast cancers associated with BRCA and BRCA mutations

Telix Receives Approval for Pixclara for Brain Cancer Imaging

Telix Pharmaceuticals has received approval from the US Food and Drug Administration FDA for Pixclara floretyrosine F or FFET a radioactive diagnostic drug used with positron emission tomography PET to image gliomas a type of brain cancer

Evonik Expands Biotechnology Manufacturing Capacity in Slovakia

Evonik has started construction of a biotechnology expansion at its Fermas site in Slovensk upa Slovakia

CordenPharma Expands Aseptic Fill-Finish Capacity to 500 Million Sterile Injectable Units Annually

CordenPharma is expanding its sterile injectable manufacturing capacity at its Caponago site in Milan Italy through a multiyear investment programme

Exegenesis Bio Enters into Collaboration with Modalis to Advance MDL-201 for Duchenne Muscular Dystrophy

Exegenesis Bio and Modalis Therapeutics have entered into a research collaboration and licence agreement to advance MDL an investigational treatment for Duchenne muscular dystrophy DMD